Application of model-informed drug development (MIDD) for dose selection in regulatory submissions for drug approval in Japan
{{output}}
Model-informed drug development (MIDD) is an approach to improve the efficiency of drug development. To promote awareness and application of MIDD in Japan, the Data Science Expert Committee of the Drug Evaluation Committee in the Japan Pharmaceutical Manufactu... ...
